Pathway as a Pharmacological Target for Herbal Medicines: An Investigation from Reduning Injection
暂无分享,去创建一个
Yonghua Wang | Chunli Zheng | Piar Ali Shar | Jianling Liu | Xuetong Chen | Wei Xiao | W. Xiao | Ke Sun | Yonghua Wang | Xuetong Chen | Chunli Zheng | Wenjuan Zhang | P. A. Shar | Jianling Liu | Zhengzhong Wang | Ke Sun | Wenjuan Zhang | Zhengzhong Wang
[1] U. Bhalla,et al. Emergent properties of networks of biological signaling pathways. , 1999, Science.
[2] Yonghua Wang,et al. Deciphering the combination principles of Traditional Chinese Medicine from a systems pharmacology perspective based on Ma-huang Decoction. , 2013, Journal of ethnopharmacology.
[3] Sun-Mee Lee,et al. Genipin Attenuates Sepsis by Inhibiting Toll-Like Receptor Signaling , 2012, Molecular medicine.
[4] Xue Xu,et al. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. , 2013, Journal of ethnopharmacology.
[5] A. Hata,et al. Targeting the TGFβ signalling pathway in disease , 2012, Nature Reviews Drug Discovery.
[6] Anne E Carpenter,et al. Small molecules discovered in a pathway screen target the Rho pathway in cytokinesis , 2010, Nature chemical biology.
[7] G. Johnson,et al. Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.
[8] Shao Li,et al. A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. , 2014, Molecular bioSystems.
[9] Huan Yang,et al. The Akt/PKB pathway: molecular target for cancer drug discovery , 2005, Oncogene.
[10] T. Thalhamer,et al. MAPKs and their relevance to arthritis and inflammation. , 2007, Rheumatology.
[11] A. Choi,et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway , 2000, Nature Medicine.
[12] Hou Ming Xu,et al. Safety of an injection with a mixture of extracts from Herba Artemisiae annuae, Fructus Gardeniae and Flos Lonicerae , 2009, Pharmacy World & Science.
[13] P. Tak,et al. NF-κB: a key role in inflammatory diseases , 2001 .
[14] Chen Dong,et al. MAP kinases in the immune response. , 2002, Annual review of immunology.
[15] K. Kröncke,et al. Nitric oxide: cytotoxicity versus cytoprotection--how, why, when, and where? , 1997, Nitric oxide : biology and chemistry.
[16] J. Christman,et al. Nuclear factor k B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy , 1998, Intensive Care Medicine.
[17] N. Mackman,et al. LPS induction of gene expression in human monocytes. , 2001, Cellular signalling.
[18] Wei Zhou,et al. Systems pharmacology strategies for drug discovery and combination with applications to cardiovascular diseases. , 2014, Journal of ethnopharmacology.
[19] Yubin Luo,et al. Inhibition of monosodium urate crystal-induced inflammation by scopoletin and underlying mechanisms. , 2012, International immunopharmacology.
[20] T. Maniatis,et al. Site-Specific Phosphorylation of IκBα by a Novel Ubiquitination-Dependent Protein Kinase Activity , 1996, Cell.
[21] P. Tak,et al. NF-kappaB: a key role in inflammatory diseases. , 2001, The Journal of clinical investigation.
[22] K. M. Rao. MAP kinase activation in macrophages , 2001, Journal of leukocyte biology.
[23] T. Maniatis,et al. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. , 1996, Cell.
[24] M. Netea,et al. The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. , 2007, Journal of lipid research.
[25] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[26] B. Kamińska. MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits. , 2005, Biochimica et biophysica acta.
[27] Keith T Flaherty,et al. Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases , 2006, Molecular Cancer Therapeutics.
[28] Dennis Normile,et al. Asian medicine. The new face of traditional Chinese medicine. , 2003, Science.
[29] D. Normile. The New Face of Traditional Chinese Medicine , 2003, Science.
[30] Xue Xu,et al. A Systems Biology Approach to Uncovering Pharmacological Synergy in Herbal Medicines with Applications to Cardiovascular Disease , 2012, Evidence-based complementary and alternative medicine : eCAM.
[31] Trey Ideker,et al. Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..
[32] Chao Huang,et al. Systems pharmacology in drug discovery and therapeutic insight for herbal medicines , 2014, Briefings Bioinform..
[33] Hua Yu,et al. A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data , 2012, PloS one.
[34] Jianxin Chen,et al. Large-scale exploration and analysis of drug combinations , 2015, Bioinform..
[35] Yonghua Wang,et al. A Systems Biology Approach to Understanding the Mechanisms of Action of Chinese Herbs for Treatment of Cardiovascular Disease , 2012, International journal of molecular sciences.
[36] L. Luo,et al. Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-kappaB and JNK/AP-1 activation. , 2009, International immunopharmacology.
[37] Sheng-Yang Wang,et al. Anti-inflammation activities of essential oil and its constituents from indigenous cinnamon (Cinnamomum osmophloeum) twigs. , 2008, Bioresource technology.
[38] Y. Surh,et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. , 2001, Mutation research.